Government ❯ Regulatory Agencies ❯ FDA

Drug Approval

Mifepristone Mifepristone Regulations Psychedelic Drugs Telehealth Regulations Regulations Opioid Test Supply Chain Management Medicine Regulation Legal Challenges FDA Regulations

Securities Class Action Filed Against ImmunityBio After FDA Flags Anktiva Marketing

Law firms are vying to lead the case before a May 26 deadline for investors.

Hawley Seeks Congressional Oversight of Mifepristone After FDA Offers No Timeline on Safety Review

Republicans Push to Restore In‑Person Rules for Abortion Pill at Fiery Senate Hearing

FDA Halts Sales of Unapproved Ingestible Fluoride for Children 3 and Under

Cytokinetics Hit With Securities Class Action Over Aficamten Timeline Disclosures

New Study Reveals Abortion Pill Complication Rate 22 Times Higher Than FDA Estimate

Novavax Shares Fall as Revenue Forecast Slashed Again

Trump Hints at Possible Abortion Pill Ban

FDA Reviews MDMA-Assisted Therapy for PTSD as Congress Pushes Psychedelic Research